pH-sensitive peptide hydrogel for glucose-responsive insulin delivery
- PMID: 28069504
- DOI: 10.1016/j.actbio.2017.01.016
pH-sensitive peptide hydrogel for glucose-responsive insulin delivery
Abstract
Glucose-responsive system is one of important options for self-regulated insulin delivery to treat diabetes, which has become an issue of great public health concern in the world. In this study, we developed a novel and biocompatible glucose-responsive insulin delivery system using a pH-sensitive peptide hydrogel as a carrier loaded with glucose oxidase, catalase and insulin. The peptide could self-assemble into hydrogel under physiological conditions. When hypoglycemia is encountered, neighboring alkaline amino acid side chains are significantly repulsed due to reduced local pH by the enzymatic conversion of glucose into gluconic acid. This is followed by unfolding of individual hairpins, disassembly and release of insulin. The glucose-responsive hydrogel system was characterized on the basis of structure, conformation, rheology, morphology, acid-sensitivity and the amount of consistent release of insulin in vitro and vivo. The results illustrated that our system can not only regulate the blood glucose levels in vitro but also in mice models having STZ-induced diabetes.
Statement of significance: In this report, we have shown the following significance supported by the experimental results. 1. We successfully developed, characterized and screened a novel pH-responsive peptide. 2. We successfully developed a novel and biocompatible pH-sensitive peptide hydrogel as glucose-responsive insulin delivery system loaded with glucose oxidase, catalase and insulin. 3. We successfully confirmed that the hydrogel platform could regulate the blood glucose level in vitro and in vivo. Overall, we have shown enough significance and novelty with this smart hydrogel platform in terms of biomaterials, peptide chemistry, self-assembly, hydrogel and drug delivery. So we believe this manuscript is suitable for Acta Biomaterialia.
Keywords: Diabetes; Glucose-responsive; Insulin-delivery; Self-assembly peptide hydrogels.
Copyright © 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Injectable self-assembled peptide hydrogels for glucose-mediated insulin delivery.Biomater Sci. 2018 May 29;6(6):1480-1491. doi: 10.1039/c8bm00006a. Biomater Sci. 2018. PMID: 29623975
-
An injectable particle-hydrogel hybrid system for glucose-regulatory insulin delivery.Acta Biomater. 2017 Dec;64:334-345. doi: 10.1016/j.actbio.2017.09.044. Epub 2017 Sep 30. Acta Biomater. 2017. PMID: 28974477
-
Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.Biomater Sci. 2019 Apr 23;7(5):2023-2036. doi: 10.1039/c9bm00139e. Biomater Sci. 2019. PMID: 30839983
-
Hydrogels for oral delivery of therapeutic proteins.Expert Opin Biol Ther. 2004 Jun;4(6):881-7. doi: 10.1517/14712598.4.6.881. Expert Opin Biol Ther. 2004. PMID: 15174970 Review.
-
Smart self-assembled hybrid hydrogel biomaterials.Angew Chem Int Ed Engl. 2012 Jul 23;51(30):7396-417. doi: 10.1002/anie.201201040. Angew Chem Int Ed Engl. 2012. PMID: 22806947 Free PMC article. Review.
Cited by
-
Glucose Oxidase-Based Glucose-Sensitive Drug Delivery for Diabetes Treatment.Polymers (Basel). 2017 Jun 29;9(7):255. doi: 10.3390/polym9070255. Polymers (Basel). 2017. PMID: 30970930 Free PMC article. Review.
-
A current era in pulsatile drug delivery system: Drug journey based on chronobiology.Heliyon. 2024 Apr 4;10(10):e29064. doi: 10.1016/j.heliyon.2024.e29064. eCollection 2024 May 30. Heliyon. 2024. PMID: 38813204 Free PMC article. Review.
-
Development of a pH-Sensitive Nanoparticle via Self-Assembly of Fucoidan and Protamine for the Oral Delivery of Insulin.Pharmaceutics. 2024 Oct 11;16(10):1323. doi: 10.3390/pharmaceutics16101323. Pharmaceutics. 2024. PMID: 39458652 Free PMC article.
-
Insights into the Role of Natural Polysaccharide-Based Hydrogel Wound Dressings in Biomedical Applications.Gels. 2022 Oct 12;8(10):646. doi: 10.3390/gels8100646. Gels. 2022. PMID: 36286147 Free PMC article. Review.
-
Self-Assembling Peptides as an Emerging Platform for the Treatment of Metabolic Syndrome.Int J Nanomedicine. 2020 Dec 21;15:10349-10370. doi: 10.2147/IJN.S278189. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33376325 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials